Relay Therapeutics RLAY
NASDAQ RLAY
$18.96 +0.47 (+2.54%)
At close: Oct 2, 2026 · 4:00 PM EDT

Relay Therapeutics (RLAY) Other Accumulated Expenses (2021 - 2026)

Updated

Relay Therapeutics' Other Accumulated Expenses was $1.25 million in Q2 2026, up 105.6% from $609,000 a year earlier and up 47.8% from the prior quarter.

Analysis

Relay Therapeutics (RLAY) Other Accumulated Expenses (2021 - 2026) Analysis & Trends

At the end of FY2025, Other Accumulated Expenses at Relay Therapeutics came in at $463,000, down 76.7% from FY2024.

  • Other Accumulated Expenses shows a four-year compound annual growth rate of 4.0% (FY2021 to FY2025).
  • In earlier years, Other Accumulated Expenses was $1.99 million in FY2024 (+65.3%), $1.2 million in FY2023 (-95.4%), $26.15 million in FY2022 and $396,000 in FY2021.
  • The Q2 2026 figure marks the highest quarterly Other Accumulated Expenses since Q1 2025.
  • Compared with a year earlier, Other Accumulated Expenses was higher in four of the last eight quarters, with growth averaging 3.5%.
  • The best year-over-year quarter for Other Accumulated Expenses over five years was Q2 2026 (growth of 105.6%); the worst was Q2 2024 (a decline of 97.0%).
  • Per Business Quant data, RLAY's Other Accumulated Expenses in the three quarters before Q2 2026 was $847,000 (Q1 2026), $463,000 (Q4 2025) and $1.08 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Relay Therapeutics 4.14 Bn 4.14 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.25 Mn
Mar 31, 2026 847,000.00
Dec 31, 2025 463,000.00
Sep 30, 2025 1.08 Mn
Jun 30, 2025 609,000.00
Mar 31, 2025 1.68 Mn
Dec 31, 2024 1.99 Mn
Sep 30, 2024 1.36 Mn
Jun 30, 2024 768,000.00
Mar 31, 2024 1.66 Mn
Dec 31, 2023 1.20 Mn
Sep 30, 2023 1.10 Mn
Jun 30, 2023 25.26 Mn
Mar 31, 2023 26.15 Mn
Dec 31, 2022 26.15 Mn
Sep 30, 2022 26.90 Mn
Jun 30, 2022 15.41 Mn
Mar 31, 2022 16.33 Mn
Dec 31, 2021 396,000.00
API Access

Relay Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=RLAY&period=max&api_key=YOUR_API_KEY